Literature DB >> 21121930

Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics.

H S Cheong1, S-M Park, M-O Kim, J-S Park, J Y Lee, J Y Byun, B L Park, H D Shin, C-S Park.   

Abstract

BACKGROUND: In addition to the dysregulation of arachidonic acid metabolism in aspirin-intolerant asthma (AIA), aspirin acetylsalicylic acid (ASA) exerts effects on inflammation and immunity; however, many of these effects are unknown.
OBJECTIVE: The aim of the study was to evaluate the methylation status of whole genome in blood and polyp tissues with and without aspirin hypersensitivity.
METHODS: Genome-wide DNA methylation levels in nasal polyps and peripheral blood cells were examined by microarray analysis using five subjects with AIA and four subjects with aspirin-tolerant asthma (ATA).
RESULTS: In the nasal polyps of the patients with AIA, hypermethylation was detected at 332 loci in 296 genes, while hypomethylation was detected at 158 loci in 141 genes. Gene ontologic and pathway enrichment analyses revealed that genes involved in lymphocyte proliferation, cell proliferation, leukocyte activation, cytokine biosynthesis, cytokine secretion, immune responses, inflammation, and immunoglobulin binding were hypomethylated, while genes involved in ectoderm development, hemostasis, wound healing, calcium ion binding, and oxidoreductase activity were hypermethylated. In the arachidonate pathway, PGDS, ALOX5AP, and LTB4R were hypomethylated, whereas PTGES was hypermethylated.
CONCLUSION: The nasal polyps of patients with AIA have characteristic methylation patterns affecting 337 genes. The genes and pathways identified in this study may be associated with the presence of aspirin hypersensitivity in asthmatics and are therefore attractive targets for future research.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21121930     DOI: 10.1111/j.1398-9995.2010.02514.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  32 in total

Review 1.  The Role of Epigenetics in the Chronic Sinusitis with Nasal Polyp.

Authors:  Tiancong Liu; Yang Sun; Weiliang Bai
Journal:  Curr Allergy Asthma Rep       Date:  2020-11-24       Impact factor: 4.806

Review 2.  Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis.

Authors:  Whitney W Stevens; Robert P Schleimer
Journal:  Immunol Allergy Clin North Am       Date:  2016-09-13       Impact factor: 3.479

3.  Impaired E Prostanoid2 Expression and Resistance to Prostaglandin E2 in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory Disease.

Authors:  Katherine N Cahill; Benjamin A Raby; Xiaobo Zhou; Feng Guo; Derek Thibault; Andreas Baccarelli; Hyang-Min Byun; Neil Bhattacharyya; John W Steinke; Joshua A Boyce; Tanya M Laidlaw
Journal:  Am J Respir Cell Mol Biol       Date:  2016-01       Impact factor: 6.914

Review 4.  Aspirin sensitivity: Lessons in the regulation (and dysregulation) of mast cell function.

Authors:  Joshua A Boyce
Journal:  J Allergy Clin Immunol       Date:  2019-10       Impact factor: 10.793

Review 5.  Pathogenesis of aspirin-exacerbated respiratory disease and reactions.

Authors:  Tanya M Laidlaw; Joshua A Boyce
Journal:  Immunol Allergy Clin North Am       Date:  2012-12-23       Impact factor: 3.479

6.  Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes.

Authors:  Tao Liu; Tanya M Laidlaw; Howard R Katz; Joshua A Boyce
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-01       Impact factor: 11.205

Review 7.  Aspirin-intolerant asthma: a comprehensive review of biomarkers and pathophysiology.

Authors:  Juan R Velazquez; Luis M Teran
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

Review 8.  Genetic and Epigenetic Components of Aspirin-Exacerbated Respiratory Disease.

Authors:  Amber Dahlin; Scott T Weiss
Journal:  Immunol Allergy Clin North Am       Date:  2016-11       Impact factor: 3.479

9.  C-590T Promoter Polymorphism of the Interleukin (IL)-4 Gene Is Associated with an Increased usceptibility to Nasal Polyposis.

Authors:  Mojgan Mohammadi; Shahriar Dabiri; Hamid Reza Mollaei; Samira Rezaee Jouzdani; Maryam Amizadeh; Jamshid Esmailzadeh; Mohammad Reza Baneshi; Aliasghar Arabi Mianroodi
Journal:  Rep Biochem Mol Biol       Date:  2019-01

Review 10.  Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease.

Authors:  Esha Sehanobish; Mohammad Asad; Mali Barbi; Steven A Porcelli; Elina Jerschow
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.